Stephen P. Robertson

CIK: 0001837798

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (41.7%)

Compensation grants

Other (G, F, J, C, D, …)3 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AUPH

Aurinia Pharmaceuticals Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

AUPH
Aurinia Pharmaceuticals Inc.
Sep 10, 2026
Sale(S)
Direct
11.9K shares at avg. $15.95$190K
AUPH
Aurinia Pharmaceuticals Inc.
Aug 21, 2026
Sale(S)
Direct
21K shares at avg. $16.97$356K
AUPH
Aurinia Pharmaceuticals Inc.
May 18, 2026
Award(A)
Direct
115.5K shares-
AUPH
Aurinia Pharmaceuticals Inc.
Mar 2, 2026
Tax Payment(F)
Direct
36.5K shares at avg. $14.21$519K
AUPH
Aurinia Pharmaceuticals Inc.
Feb 27, 2026
Award(A)
Direct
59.1K shares-
AUPH
Aurinia Pharmaceuticals Inc.
Feb 20, 2026
Tax Payment(F)
Direct
34.6K shares at avg. $14.40$499K
AUPH
Aurinia Pharmaceuticals Inc.
Jan 2, 2026
Award(A)
Direct
48.6K shares-
AUPH
Aurinia Pharmaceuticals Inc.
Jan 2, 2026
Tax Payment(F)
Direct
40.4K shares at avg. $15.95$644K
AUPH
Aurinia Pharmaceuticals Inc.
Mar 4, 2025
Sale(S)
Direct
57.6K shares at avg. $7.92$456K
AUPH
Aurinia Pharmaceuticals Inc.
Mar 3, 2025
Award(A)
Direct
102.4K shares-
AUPH
Aurinia Pharmaceuticals Inc.
Mar 3, 2025
Sale(S)
Direct
64.9K shares at avg. $8.00$519K
AUPH
Aurinia Pharmaceuticals Inc.
Feb 28, 2025
Award(A)
Direct
84.1K shares-

		Type	Shares	Price		Ownership
Sep 10, 2026	AUPH Aurinia Pharmaceuticals Inc.	Sale(S)	11,939	$15.95	$190,427	Direct
Aug 21, 2026	AUPH Aurinia Pharmaceuticals Inc.	Sale(S)	20,975	$16.97	$355,946	Direct
May 18, 2026	AUPH Aurinia Pharmaceuticals Inc.	Award(A)	115,541	-	$0	Direct
Mar 2, 2026	AUPH Aurinia Pharmaceuticals Inc.	Tax Payment(F)	36,525	$14.21	$519,020	Direct
Feb 27, 2026	AUPH Aurinia Pharmaceuticals Inc.	Award(A)	59,090	-	$0	Direct
Feb 20, 2026	AUPH Aurinia Pharmaceuticals Inc.	Tax Payment(F)	34,638	$14.40	$498,787	Direct
Jan 2, 2026	AUPH Aurinia Pharmaceuticals Inc.	Award(A)	48,558	-	$0	Direct
Jan 2, 2026	AUPH Aurinia Pharmaceuticals Inc.	Tax Payment(F)	40,385	$15.95	$644,141	Direct
Mar 4, 2025	AUPH Aurinia Pharmaceuticals Inc.	Sale(S)	57,607	$7.92	$456,247	Direct
Mar 3, 2025	AUPH Aurinia Pharmaceuticals Inc.	Award(A)	102,406	-	-	Direct
Mar 3, 2025	AUPH Aurinia Pharmaceuticals Inc.	Sale(S)	64,872	$8.00	$518,976	Direct
Feb 28, 2025	AUPH Aurinia Pharmaceuticals Inc.	Award(A)	84,106	-	-	Direct

1-12 of 12 transactions

About Robertson Stephen P.

Robertson Stephen P. (SEC CIK 0001837798) files insider reports with the SEC as Chief Legal Officer of Aurinia Pharmaceuticals Inc. (AUPH).

Signal8 holds 7 ownership filings by Robertson Stephen P., all Form 4s, filed between Mar 4, 2025 and Sep 11, 2026. Those filings report 12 transactions, from Feb 28, 2025 to Sep 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Robertson Stephen P.'s filings is in EDMONTON.

Recent filings by Robertson Stephen P.

Sep 10, 2026: Open-market sale of AUPH shares (Form 4, code S).
Aug 21, 2026: Open-market sale of AUPH shares (Form 4, code S).
May 18, 2026: Grant or award of AUPH shares (Form 4, code A).
Mar 2, 2026: Tax withholding of AUPH shares (Form 4, code F).
Feb 27, 2026: Grant or award of AUPH shares (Form 4, code A).

Other insiders filing for Aurinia Pharmaceuticals Inc. (AUPH)

Johnson Craig A, Director
Goetz Kathleen, Director
Nova Tina Susan, Director
Bailey Jeffrey Allen, Director
TANG KEVIN, Chief Executive Officer
Hearne Michael S, Chief Financial Officer

How to read Form 4 transaction codes